Stocks
Alnylam Pharmaceuticals, Inc.ALNY
NASDAQHealthcareBiotechnology$249.46-1.20%
Price as of · delayed, not real-time
A biopharmaceutical company focused on discovering and developing RNA interference (RNAi) therapeutics for genetically defined diseases. Its pipeline includes treatments for rare genetic, cardio-metabolic, and hepatic infectious diseases, making it a key player in the precision medicine space. Investors monitor Alnylam for its innovative platform and potential blockbuster drugs in late-stage trials.
Market Cap: $41.6B52W Range: $197.81-$495.55
Congressional Interest in Alnylam Pharmaceuticals, Inc. (ALNY)
10 members of Congress have disclosed 33 trades in Alnylam Pharmaceuticals, Inc. (ALNY), a Healthcare company. The buy/sell breakdown shows 17 purchases versus 16 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
33
Unique Politicians
10
Buys
17
Sells
16
Who in Congress Is Trading ALNY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-08-11 | Cory A Booker | sell | $1K-$15K |
| 2025-05-12 | Jefferson Shreve | sell | $15K-$50K |
| 2024-11-19 | MICHAEL T. MCCAUL | sell | $50K-$100K |
| 2024-11-01 | Josh Gottheimer | buy | $1K-$15K |
| 2024-01-29 | Josh Gottheimer | sell | $1K-$15K |
| 2024-01-11 | Josh Gottheimer | buy | $1K-$15K |
| 2023-12-11 | Josh Gottheimer | sell | $1K-$15K |
| 2023-03-06 | Daniel Goldman | buy | $15K-$50K |
| 2023-01-31 | Daniel Goldman | sell | $15K-$50K |
| 2022-09-28 | Josh Gottheimer | buy | $1K-$15K |
| 2020-11-13 | Josh Gottheimer | sell | $1K-$15K |
| 2020-04-06 | Josh Gottheimer | buy | $1K-$15K |
| 2020-01-06 | David P. Roe | buy | $1K-$15K |
| 2019-08-21 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2018-10-23 | JOHN K. DELANEY | buy | $1K-$15K |
| 2018-10-18 | Josh Gottheimer | sell | $1K-$15K |
| 2018-06-01 | Josh Gottheimer | buy | $1K-$15K |
| 2018-03-05 | Barbara J. Comstock | sell | $15K-$50K |
| 2017-10-12 | Barbara J. Comstock | buy | $15K-$50K |
| 2016-12-30 | Richard L. Hanna | sell | $1K-$15K |
| 2016-12-30 | Richard L. Hanna | buy | $50K-$100K |
| 2016-12-13 | Richard L. Hanna | sell | $100K-$250K |
| 2016-11-16 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2016-11-11 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2016-11-02 | MICHAEL T. MCCAUL | buy | $50K-$100K |
| 2016-10-13 | Richard L. Hanna | buy | $100K-$250K |
| 2016-10-05 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2016-10-03 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2015-12-18 | MICHAEL T. MCCAUL | sell | $15K-$50K |
| 2015-11-05 | JOHN K. DELANEY | buy | $1K-$15K |
| 2015-07-31 | JAMES B. RENACCI | buy | $15K-$50K |
| 2015-06-24 | JOHN K. DELANEY | buy | $15K-$50K |
| 2015-03-03 | JOHN K. DELANEY | buy | $1K-$15K |